Deceptive Advertising! Claims Novo in GLP-1 Lawsuit Fallout
Two pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
Identify practical steps to cushion unexpected bills, including setting aside a dedicated fund and tracking variable costs. Begin building resilience now.
12,518 articlesTwo pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
A leading Bundesbank official hints at euro-pegged stablecoins as a tool to reduce dollar dominance. This analysis ex...
SMR stocks like NuScale Power and Oklo have dazzled investors, but 2026 could test whether execution, not hype, drive...
A practical, reader-friendly guide to what to expect in evaxion (evax) 2025 earnings. Learn the drivers, read the cal...
Rivian has faced a steep stock decline since its 2021 IPO. This piece explores whether could this catalyst that sits ...
Oil traders are weighing a hypothetical '$200 trump radar' scenario as prices approach extreme levels. This report ex...
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
The first-quarter earnings season is more than a quarterly ritual. It’s a blueprint for 2026, showing how AI investme...
A new analysis links AI exposure to blue-state counties, signaling how AI policy could reshape personal finances and ...
Bitcoin has clawed back from the $60,000 zone and sits near $65,000 as markets brace for the Federal Reserve’s policy...
Billionaire investor Ken Griffin donates $26 million to fund the west wing of the Theodore Roosevelt Presidential Lib...
A leading economist argues AI-driven productivity is slow to spread beyond software, suggesting investors should brac...